Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific's reverse split of its common stock has taken effect, the firm announced today.

The 1-for-300 reverse split reduced the number of common stock shares from 199 million to 663,334 and was approved by the Financial Industry Regulatory Authority, following a special shareholder vote.

Also, Great Basin increased its number of authorized shares of common stock from 200 million to 1.5 billion shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
24

This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.